Additionally, STn expression was assessed in pancreatic ductal adenocarcinoma (PDAC) patient-derived xenografts (PDXs), a potential tool for testing new anti-STn therapeutic approaches for PC. The gene discussed is EEF1A2; the disease is pancreatic ductal adenocarcinoma.